As part of the Super Elongation Complex (SEC), CDK9 is important for transcriptional elongation, in particular in KMT2A-r AML63, it is therefore rational to evaluate the efficacy of fadraciclib in this AML subtype. The gene discussed is CDK9; the disease is acute myeloid leukemia.